Phillips, AN;
Cambiano, V;
Nakagawa, F;
Ford, D;
Apollo, T;
Murungu, J;
Rousseau, C;
... Revill, P; + view all
(2016)
Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile.
Open Forum Infectious Diseases
, 3
(3)
, Article ofw161. 10.1093/ofid/ofw161.
Preview |
Text
phillips_Open Forum Infect Dis-2016-Phillips-.pdf Download (355kB) | Preview |
Abstract
Point-of-care viral load tests are being developed to monitor patients on antiretroviral therapy (ART) in sub-Saharan Africa. Test design involves trade-offs between test attributes, including accuracy, complexity, robustness, and cost. We used a model of the human immunodeficiency virus epidemic and ART program in Zimbabwe and found that the attributes of a viral load testing approach that are most influential for cost effectiveness are avoidance of a high proportion of failed tests or results not received, use of an approach that best facilitates retention on ART, and the ability to facilitate greater use of differentiated care, including through expanding coverage of testing availability.
Type: | Article |
---|---|
Title: | Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1093/ofid/ofw161 |
Publisher version: | http://doi.org/10.1093/ofid/ofw161 |
Language: | English |
Additional information: | © The Author 2016. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
Keywords: | Antiretroviral therapy, cost-effectiveness, model, point-of-care, viral load |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
URI: | https://discovery.ucl.ac.uk/id/eprint/1516133 |
Archive Staff Only
View Item |